NO20030495L - Peptider som presenteres av celler - Google Patents
Peptider som presenteres av cellerInfo
- Publication number
- NO20030495L NO20030495L NO20030495A NO20030495A NO20030495L NO 20030495 L NO20030495 L NO 20030495L NO 20030495 A NO20030495 A NO 20030495A NO 20030495 A NO20030495 A NO 20030495A NO 20030495 L NO20030495 L NO 20030495L
- Authority
- NO
- Norway
- Prior art keywords
- peptides
- cells
- determination
- peptides presented
- relates
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Optics & Photonics (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0018901.9A GB0018901D0 (en) | 2000-08-03 | 2000-08-03 | Peptides presented by cells |
| PCT/EP2001/008625 WO2002012899A2 (en) | 2000-08-03 | 2001-07-26 | Peptides presented by cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030495L true NO20030495L (no) | 2003-01-31 |
| NO20030495D0 NO20030495D0 (no) | 2003-01-31 |
Family
ID=9896790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030495A NO20030495D0 (no) | 2000-08-03 | 2003-01-31 | Peptider som presenteres av celler |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20030171290A1 (no) |
| EP (1) | EP1305343B1 (no) |
| JP (1) | JP2004506202A (no) |
| KR (1) | KR20030037272A (no) |
| CN (1) | CN1511164A (no) |
| AT (1) | ATE306498T1 (no) |
| AU (1) | AU2001283958A1 (no) |
| BR (1) | BR0112925A (no) |
| CA (1) | CA2417767A1 (no) |
| CZ (1) | CZ2003464A3 (no) |
| DE (1) | DE60114018T2 (no) |
| GB (1) | GB0018901D0 (no) |
| HU (1) | HUP0301581A2 (no) |
| MX (1) | MXPA03000901A (no) |
| NO (1) | NO20030495D0 (no) |
| PL (1) | PL358874A1 (no) |
| RU (1) | RU2003105806A (no) |
| SK (1) | SK1982003A3 (no) |
| WO (1) | WO2002012899A2 (no) |
| ZA (1) | ZA200301637B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001292778A1 (en) * | 2000-09-18 | 2002-03-26 | Genzyme Corporation | Method to identify therapeutic antibody targets associated with a therapeutic response |
| US20040235062A1 (en) * | 2001-06-19 | 2004-11-25 | Terumi Nakajima | Method of analyzing protein occurring in cell or substance interacting with the protein |
| EP2481422A3 (en) * | 2003-09-03 | 2013-04-03 | Dendritherapeutics, Inc. | Multiplex vaccines |
| ES2358427T3 (es) | 2003-10-16 | 2011-05-10 | Micromet Ag | Elementos de unión a cd-3 desinmunizados multiespecíficos. |
| US20090061478A1 (en) * | 2006-01-30 | 2009-03-05 | Lene Have Poulsen | High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry |
| EP2155782A2 (en) | 2007-03-26 | 2010-02-24 | Dako Denmark A/S | Mhc peptide complexes and uses thereof in infectious diseases |
| EP2167537A2 (en) | 2007-07-03 | 2010-03-31 | Dako Denmark A/S | Compiled methods for analysing and sorting samples |
| WO2009039854A2 (en) | 2007-09-27 | 2009-04-02 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
| DK2254592T3 (da) | 2008-02-28 | 2019-09-09 | Dako Denmark As | MHC-multimerer til Borrelia-diagnostik og sygdom |
| US10722562B2 (en) * | 2008-07-23 | 2020-07-28 | Immudex Aps | Combinatorial analysis and repair |
| GB0817244D0 (en) * | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
| WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
| EP2496257A4 (en) | 2009-11-05 | 2013-02-27 | Cephalon Australia Pty Ltd | TREATMENT OF CANCER CHARACTERIZED BY THE MUTATION OF KRAS OR BRAF GENES |
| US20150017136A1 (en) * | 2013-07-15 | 2015-01-15 | Cellectis | Methods for engineering allogeneic and highly active t cell for immunotherapy |
| WO2014184744A1 (en) * | 2013-05-13 | 2014-11-20 | Cellectis | Methods for engineering highly active t cell for immunotherapy |
| MX2018007204A (es) | 2015-12-16 | 2018-12-11 | Gritstone Oncology Inc | Identificacion, fabricacion y uso de neoantigeno. |
| CA3002520A1 (en) * | 2016-09-30 | 2018-04-05 | Cellex Life Sciences, Incorporated | Compositions containing protein loaded exosome and methods for preparing and delivering the same |
| WO2019075112A1 (en) | 2017-10-10 | 2019-04-18 | Gritstone Oncology, Inc. | IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS |
| CA3083097A1 (en) | 2017-11-22 | 2019-05-31 | Gritstone Oncology, Inc. | Reducing junction epitope presentation for neoantigens |
| WO2020127222A2 (en) | 2018-12-17 | 2020-06-25 | Immudex Aps | Panel comprising borrelia mhc multimers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE319745T1 (de) * | 1997-05-21 | 2006-03-15 | Biovation Ltd | Verfahren zur herstellung von nicht-immunogenen proteinen |
| AU776910B2 (en) * | 1998-12-08 | 2004-09-23 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Modifying protein immunogenicity |
| AU4676500A (en) * | 1999-04-28 | 2000-11-10 | Northwestern University | Localization of major peptide autoepitopes for nucleosome specific t cells of systemic lupus erythematosus |
-
2000
- 2000-08-03 GB GBGB0018901.9A patent/GB0018901D0/en not_active Ceased
-
2001
- 2001-07-26 US US10/343,443 patent/US20030171290A1/en not_active Abandoned
- 2001-07-26 EP EP01962874A patent/EP1305343B1/en not_active Expired - Lifetime
- 2001-07-26 WO PCT/EP2001/008625 patent/WO2002012899A2/en active IP Right Grant
- 2001-07-26 KR KR10-2003-7001568A patent/KR20030037272A/ko not_active Application Discontinuation
- 2001-07-26 CN CNA01813694XA patent/CN1511164A/zh active Pending
- 2001-07-26 HU HU0301581A patent/HUP0301581A2/hu unknown
- 2001-07-26 BR BR0112925-2A patent/BR0112925A/pt not_active IP Right Cessation
- 2001-07-26 CA CA002417767A patent/CA2417767A1/en not_active Abandoned
- 2001-07-26 MX MXPA03000901A patent/MXPA03000901A/es unknown
- 2001-07-26 RU RU2003105806/13A patent/RU2003105806A/ru not_active Application Discontinuation
- 2001-07-26 AT AT01962874T patent/ATE306498T1/de not_active IP Right Cessation
- 2001-07-26 PL PL01358874A patent/PL358874A1/xx unknown
- 2001-07-26 CZ CZ2003464A patent/CZ2003464A3/cs unknown
- 2001-07-26 DE DE60114018T patent/DE60114018T2/de not_active Expired - Lifetime
- 2001-07-26 AU AU2001283958A patent/AU2001283958A1/en not_active Abandoned
- 2001-07-26 SK SK198-2003A patent/SK1982003A3/sk not_active Application Discontinuation
- 2001-07-26 JP JP2002517532A patent/JP2004506202A/ja active Pending
-
2003
- 2003-01-31 NO NO20030495A patent/NO20030495D0/no unknown
- 2003-02-27 ZA ZA200301637A patent/ZA200301637B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2003464A3 (cs) | 2003-06-18 |
| JP2004506202A (ja) | 2004-02-26 |
| US20030171290A1 (en) | 2003-09-11 |
| HUP0301581A2 (hu) | 2003-08-28 |
| SK1982003A3 (en) | 2003-08-05 |
| DE60114018T2 (de) | 2006-06-29 |
| KR20030037272A (ko) | 2003-05-12 |
| AU2001283958A1 (en) | 2002-02-18 |
| NO20030495D0 (no) | 2003-01-31 |
| ZA200301637B (en) | 2004-02-03 |
| EP1305343B1 (en) | 2005-10-12 |
| EP1305343A2 (en) | 2003-05-02 |
| PL358874A1 (en) | 2004-08-23 |
| CA2417767A1 (en) | 2002-02-14 |
| BR0112925A (pt) | 2003-08-26 |
| CN1511164A (zh) | 2004-07-07 |
| RU2003105806A (ru) | 2004-07-20 |
| GB0018901D0 (en) | 2000-09-20 |
| MXPA03000901A (es) | 2003-06-24 |
| DE60114018D1 (de) | 2006-02-23 |
| WO2002012899A2 (en) | 2002-02-14 |
| WO2002012899A3 (en) | 2002-11-07 |
| ATE306498T1 (de) | 2005-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030495D0 (no) | Peptider som presenteres av celler | |
| EP2338333A3 (en) | Glycopegylation methods and proteins/peptides produced by the methods | |
| ATE464067T1 (de) | Bindegewebs wachstumsfaktor (ctgf) | |
| ATE380822T1 (de) | Funf-helix protein | |
| AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
| WO2002002783A3 (en) | Expression vectors | |
| EA200100589A1 (ru) | Азабициклоалканы как модуляторы ccr5 | |
| WO2005014035A3 (en) | Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest | |
| WO1996034107A3 (en) | Antiviral proteins, dna coding sequences therefor, and uses thereof | |
| WO2003106657A3 (en) | NUCLEOTIDE SEQUENCES AND AMINO ACID SEQUENCES WISE / SOST | |
| EP2275554A3 (en) | Neisserial antigenic peptides | |
| ATE481480T1 (de) | Methoden und zusammensetzungen zur herstellung von polypeptiden | |
| WO2004007547A3 (en) | Truncated tau proteins | |
| DE60313659D1 (de) | Borrelidin-derivate und ihre medizinische anwendung | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| WO1999054349A3 (en) | Dermatophagoides nucleic acid molecules, proteins and uses thereof | |
| WO2004081033A3 (en) | Synthesis of proteins by cell-free protein expression | |
| WO2001029220A3 (en) | Mage-a12 antigenic peptides and uses thereof | |
| AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
| WO2002074921A3 (en) | Methods for isolating proteins expressed by dendritic cells | |
| WO2001066709A3 (en) | Sphingomyelinase enzymes and uses relating thereto | |
| WO1998051782A3 (en) | Human 3-hydroxyisobutyryl-coenzyme a hydrolase | |
| WO2002062964A3 (en) | Ap1 amine oxidase variants | |
| WO2003025197A3 (en) | Mutant sh3-binding protein compositions and methods | |
| WO1998041538A3 (en) | Novel human cytokine/steroid receptor protein |